Eli Lilly and Company (LLY)
Quick ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | US$ in thousands | 2,818,600 | 2,380,800 | 2,694,500 | 3,545,900 | 2,067,000 | 2,617,400 | 2,622,900 | 2,459,200 | 3,818,500 | 3,788,200 | 3,220,000 | 3,002,400 | 3,657,100 | 3,595,300 | 2,365,100 | 1,699,000 | 2,337,500 | 1,563,800 | 2,290,200 | 2,036,400 |
Short-term investments | US$ in thousands | 109,100 | 113,100 | 134,600 | 123,400 | 144,800 | 124,700 | 113,800 | 109,100 | 90,100 | 37,100 | 51,200 | 49,000 | 24,200 | 35,000 | 22,800 | 78,400 | 101,000 | 89,200 | 77,700 | 100,700 |
Receivables | US$ in thousands | 11,336,200 | 10,363,800 | 9,171,400 | 9,022,100 | 6,896,000 | 8,324,800 | 7,672,400 | 7,805,700 | 6,672,800 | 7,025,000 | 6,902,800 | 6,658,600 | 5,875,300 | 5,844,800 | 5,775,600 | 6,352,500 | 4,547,300 | 5,537,900 | 5,590,000 | 5,178,000 |
Total current liabilities | US$ in thousands | 27,293,200 | 21,998,200 | 18,915,000 | 16,010,000 | 17,138,200 | 15,652,800 | 15,620,600 | 13,386,000 | 15,052,700 | 13,682,000 | 15,093,200 | 11,714,200 | 12,481,600 | 11,976,900 | 11,988,500 | 12,610,200 | 11,775,200 | 10,828,600 | 11,855,400 | 11,236,100 |
Quick ratio | 0.52 | 0.58 | 0.63 | 0.79 | 0.53 | 0.71 | 0.67 | 0.77 | 0.70 | 0.79 | 0.67 | 0.83 | 0.77 | 0.79 | 0.68 | 0.64 | 0.59 | 0.66 | 0.67 | 0.65 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($2,818,600K
+ $109,100K
+ $11,336,200K)
÷ $27,293,200K
= 0.52
The quick ratio of Lilly(Eli) & Co has been fluctuating over the past eight quarters, ranging from a low of 0.73 in Q4 2023 to a high of 1.02 in Q1 2023. The quick ratio measures the company's ability to meet its short-term obligations using its most liquid assets, excluding inventory. A quick ratio below 1 indicates that the company may have difficulty meeting its short-term liabilities with its current liquid assets alone.
The downward trend observed from Q1 2023 to Q4 2023 could suggest potential liquidity challenges for the company in the near term. However, it is essential to consider other factors such as the industry norms and the company's operating cycle when interpreting the quick ratio in isolation.
As an analyst, further investigation into the composition of current assets and liabilities, as well as any significant changes in operating activities, would provide a more nuanced understanding of Lilly(Eli) & Co's liquidity position.
Peer comparison
Dec 31, 2023